The Board of the NBA

Norwegian Bioindustry Association’s board 2011-2011 (Annual General Meeting was held 20. juni 2011)

Bjørn Fuglaas, Director, GE Healthcare AS (chairman)

Marianne Nesje, Patent Manager, Axellia Pharmaceuticals AS (deputy chairman)

Edel Anne Norderhus, Director, Pharmaq AS (new)

Johan C. Løken, Chairman, Graminor AS / BioInn

Jan A. Alfheim, Chief Business Officer, Clavis Pharma AS (new)

Emilie Lasson, Senior Market Development Manager Invitrogen Dynal AS

Torfinn Hansen, CEO Pfizer AS



Deputy members:

Varamedlemmer:

Ivar Lossius, Advisor, Uniresearch AS/Bioprotein AS

Berit Iversen, Manager CMC and QA, Lytix Biopharma AS (new)

Brit Rønning Johansen, Market Analyst, Weifa AS

Subscription:
Membership in the Association is free of charge for members of NHO. Non-NHO-members must pay a subscription.